News search

    E.g., 19/02/2026
    E.g., 19/02/2026
    Raquel Martínez de Meno, Rebeca Acín Pérez, José Antonio Enríquez, Sara Jaroszewicz y Rebeca Sanz-Cortés.
    Research
    16 Feb 2026
    Nature Metabolism: A yeast enzyme helps human cells overcome mitochondrial defects[

    A new CNIC-led study shows that a genetic tool derived from baker’s yeast enables human cells to manufacture the building blocks of DNA even when their mitochondria fail.
    Ana Simón Chica y David Filgueiras Rama
    Research
    10 Feb 2026
    Circulation Research: Study reveals new cellular mechanisms that allow the most common chronic cardiac arrhythmia to persist in the heart

    The study, published in Circulation Research, identifies cardiac fibroblasts and resident macrophages as essential contributors to the characteristic electrical activity that maintains this arrhythmia
    Equipo de investigadores del CNIC liderados por la Dr. Mª Ángeles Moro. De izquierda a derecha, primera fila: Ignacio Lizasoain, Gaohong Di, Maria Angeles Moro, Alicia García-Culebras, Maria Isabel Cuartero, Francisco J. de Castro-Millan, Abndrea Rubio-Ponce, Carlos Parra-Pérez, Christina Reyburn-Valés, Carlona Peña-Martinez, Marta Marty. Segunda fila: Francisco Cantero-Molina, Eneko Merino-Casamayor, Virginia García-Sánchez, Laiura Martínez-. Cortés, Hana Matuskova, Emily McMahon
    Research
    20 Jan 2026
    Circulation Research: The body’s internal clock influences stroke severity and response to treatment

    The study, published in Circulation Research, reveals that neutrophils—key immune cells—change their behavior in line with circadian rhythms, affecting cerebral perfusion and collateral circulation
    Héctor Bueno JACARDI
    About the CNIC
    15 Dec 2025
    The Lancet: Five decisive actions to transform Europe’s NCD monitoring systems: “What gets measured gets prioritised”

    A new policy paper highlights key areas for advancing data-driven policymaking to curb the rising burden of non-communicable diseases (NCDs), setting the stage for a more effective and equitable healthcare in Europe 
    Protection against blood vessel occlusion in animals with sickle cell anemia after treatment with circadian clock inhibitors. Vessel walls are shown as white lines, neutrophils in yellow, and red blood cells trapped by neutrophils in red.
    Research
    12 Dec 2025
    JEM: Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

    A CNIC study reveals that neutrophils—a type of immune cell—are less aggressive at night, explaining why nighttime heart attacks are less severe than those occurring during the day
    Jorge Alegre-Cebollada
    About the CNIC
    25 Sep 2025
    Jorge Alegre-Cebollada awarded the Michael and Kate Bárány Prize 2026

    Dr. Alegre-Cebollada will be recognized for the pioneering the study of protein mechanics in living systems, revealing how mechanical forces govern protein function and contribute to human disease.
    David del Río-Aledo, Rubén Mota, Fátima Sánchez-Cabo, Carlos Torroja, Daniel Morales-Cano, Raúl Izquierdo-Serrano, Paula Nogales, Jesús Mateo, Leticia González-Cintado, Laura Carramolino y Ana Dopazo.
    Research
    12 Aug 2025
    Science Translational Medicine: A hospital imaging technique used in cancer care improves the monitoring and treatment of atherosclerosis

    El 18FDG-PET is a type of positron emission tomography that measures how much energy the body’s cells consume.
    Marina Rosa Moreno, Fátima Sánchez Cabo, José Luis Cabrera, José Antonio Enríquez, María Concepción Jiménez, Pablo Hernansanz Agustín Lucía Sánchez-García.
    Research
    2 Jul 2025
    Cell Genomics: CNIC scientists reveal how the cellular energy system evolved—and how this knowledge could improve the diagnosis of rare genetic diseases

    CNIC researchers have uncovered the evolutionary logic of the OxPhos system—the cell’s “engine”—and developed a tool to detect mutations that cause mitochondrial disease
    Dr. Eduardo Marbán
    Research
    18 Jun 2025
    Eduardo Marbán: "We have designed a cellular product called Deramiocel, and until now, we have had positive results in at least two clinical trials"
    Sarai Martínez Cano, Marcos Femenía Muiña, Elena Hernández, Vanessa Núñez, Manuel Rodrigo Tapias, Miguel Galán Burgos, Iñaki Robles, Alberto Benguria, David Sancho y Almudena Ramiro
    Research
    2 Jun 2025
    Circulation Research: CNIC scientists uncover how the immune response drives atherosclerosis—the root cause of heart attacks and strokes

    A team from the CNIC has discovered the key role of conventional type 1 dendritic cells (cDC1) in atherosclerosis and has developed an experimental therapy with immunosuppressive nanoparticles that slows the progression of the disease in animal models.